07.11.26 -- Outsourced Pharma Newsletter - Best Of June

For sponsors rethinking China-exposed supply chains, BIOSECURE is less a warning label than a stress test for redundancy, oversight, data control, and operational resilience.

Would you like a shortcut to failure in regulatory CMC? Hire extensively based on what candidates already know. That’s a provocation underlying a number of conversations with senior leaders in regulatory CMC, and it feels especially relevant to outsourcing. With the correct attitude and leadership, learning (yes, on the job) may beat credentials for long-term success.

Through more than a dozen editorials starting in February of 2024, Chief Editor Louis Garguilo has disagreed a most reliable, trusted, and thus utilized global CDMO deserves to be brandished as off-limits to U.S. drug sponsors. Here we are again: WuXi AppTec is included in the Pentagon’s new list of companies said to have ties to the Chinese government and military. Here is Garguilo's update.

When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.

Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

Platform biotech companies face critical choices on partnering, licensing, or selling technology—decisions that shape focus, valuation, and long‑term success beyond scientific innovation alone.